Business Description
Founded in 1999 and based in Abingdon, UK, Immunocore is a global biopharmaceutical company that creates treatments designed to direct the immune system against cancer, infectious diseases, and autoimmune conditions. Its approved product, KIMMTRAK, treats a rare and aggressive form of eye cancer, while its broader pipeline includes several therapies in clinical testing targeting various cancers, HIV, and hepatitis B. The company is also in the early stages of exploring treatments for type 1 diabetes and a common skin condition called atopic dermatitis.
